Search for: "BRISTOL MYERS SQUIBB"
Results 741 - 760
of 866
Sort by Relevance
|
Sort by Date
10 Feb 2009, 7:55 am
For other companies, such as Bristol-Myers Squibb, the meeting was more of a listening exercise for board directors. [read post]
6 Feb 2009, 11:20 am
Thanks in part to DTC (direct to consumer) advertising, Abilify is becoming the drug of choice.At $450 per month is it any wonder that Abilify is the darling of maker Bristol-Myers Squibb? [read post]
5 Feb 2009, 6:32 am
A February 4, 2008 Reuters article, "US FDA lists drugs under review for safety issues", provided this overview of the FDA's current list of drugs with so-called "safety signals": The products under review included schizophrenia drug Abilify, one of Bristol-Myers Squibb Co's (BMY.N) fastest- growing products. [read post]
31 Jan 2009, 6:54 am
• Bristol-Myers Squibb posted a quarterly profit of $1.24 billion. [read post]
23 Jan 2009, 9:59 pm
In addition, Peptimmune will be entitled to royalties on drug sales.BMS to License HCV Therapy from Zymogenetics Bristol-Myers Squibb (BMS) and ZymoGenetics recently announced a licensing deal for ZymoGenetics' hepatitis C therapy... [read post]
18 Jan 2009, 4:48 pm
Dasatinib is an anti-cancer drug belonging to the class of tyrosine kinase inhibitors first approved in the United States on June 28, 2006 and marketed by Bristol-Myer Squibb (BMS) under the brand name Sprycel. [read post]
15 Jan 2009, 3:35 am
Just to recap then, the High Court of Delhi recently granted an ex parte restraining order in favour of Bristol Myers Squibb restraining the defendants, Hetero Drugs (an Indian generic firm) from manufacturing, selling, distributing, advertising, exporting, offering for sale or in any manner dealing directly or indirectly in any product infringing the plaintiffs product patent covering Dasatinib, a drug used in the treatment of Chronic Myloeid Leukemia. [read post]
13 Jan 2009, 7:43 am
Walden Asset Management is urging the Securities and Exchange Commission to reject requests by Bristol-Myers Squibb and other companies to exclude proposals filed by investors affiliated with California-based activist John Chevedden. [read post]
9 Jan 2009, 10:56 am
" For 2009, Davis also refiled proposals seeking more disclosure about executive compensation (at Bristol-Myers Squibb, Comcast, and Con Edison) and to prohibit stock options, at Continental Airlines, Pfizer, and Verizon. [read post]
9 Jan 2009, 3:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Humira (Adalimumab) – US: Bayer HealthCare files patent infringement suit against Abbott Laboratories over Humira; Abbott fires back with lawsuit claiming Bayer’s patent invalid, not infringed or unenforceable (Law360) (Law360) (Philip Brooks' Patent Infringement Updates) (Patent Baristas) Sprycel (Dasatinib)… [read post]
31 Dec 2008, 6:51 pm
Recent news reports have allowed us to add thirteen biotech/pharma companies and a trade group to the list: • The Pharmaceutical Research and Manufacturers of America (PhRMA), which has more than 30 members including Bristol-Myers Squibb Co., GlaxoSmithKline PLC, Johnson & Johnson, Merck & Co., Novartis Corp., Pfizer Inc., and Sanofi-Aventis SA, spent more than $5.4 million on third quarter lobbying (see… [read post]
16 Dec 2008, 5:16 am
., and Bristol-Myers Squibb Sanofi Pharmaceuticals Holding Partnership (collectively, Sanofi) brought suit under 35 U.S.C. [read post]
15 Dec 2008, 9:51 pm
The '265 patent covers clopidogrel bisulfate, the active ingredient in Sanofi and Bristol-Myers Squibb's blockbuster heart medication Plavix. [read post]
15 Dec 2008, 2:00 pm
Shortly after the drug hit the market, Sanofi-Synthelabo, which owns the Plavix patent, and Bristol-Myers Squibb, owner of the Plavix marketing rights, sought and obtained an injunction barring sales of the generic. [read post]
3 Dec 2008, 2:00 pm
But there are potential pitfalls lurking, including one case involving Bristol-Myers Squibb's blood thinner Plavix and AstraZeneca's heartburn drug Prilosec. [read post]
21 Nov 2008, 3:43 pm
Their production companies are looking at Andy Behrman's tell-all about his days as spokesman for Bristol-Myers Squibb's schizophrenia med, Abilify.Behrman, author of "Electroboy: A Memoir of Mania," calls his latest "Adventures in the Drug Trade: I Was a Big Pharma-Pusher. [read post]
17 Nov 2008, 12:07 pm
In the white collar arena, his term will be remembered for, among other things, the deferred-prosecution agreement with Bristol-Myers Squibb (though the securities fraud prosecutions of two former executives haven’t exactly gone according to plan), and his office’s prosecution of former executives involved in accounting fraud at Cendant Corp. [read post]
31 Oct 2008, 11:53 am
You can separately subscribe to the Pharma & Biotech edition of the IP Think Tank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com] Highlights this week included: Oxytrol (Oxybutynin) - US: Watson files patent infringement lawsuit against Barr over application to market generic Oxytrol; Barr challenges Oxytrol patent… [read post]
23 Oct 2008, 10:18 am
The Wall Street Journal writes, During his five years as chief executive of Bristol-Myers Squibb ...peterrost.blogspot.com/2006/08/bye-bye-peter-dolan-hello-karen-katen.html - 67k - Cached - Similar pages - Note thisTHE PETER ROST BLOG: Pfizer CEO eliminates Karen Katen executivesJan 23, 2007 ... [read post]
15 Oct 2008, 3:02 pm
Much of the lobbying efforts were aimed at Sheldon Bradshaw, who had succeeded Daniel Troy as FDA chief counsel in April 2005.AAJ obtained emails that list attendees of a meeting between Bradshaw and the Pharmaceutical Research and Manufacturers of America (PhRMA) revealing the FDA chief counsel met with legal representatives from Pfizer, Wyeth, Eli Lilly, Berlex, Organon, Abbott Laboratories, Takeda, Sanofi-Aventis, Serono, AstraZeneca, Cephalon, Millenium, Eisai, Amgen, Astellas, GlaxoSmithKline,… [read post]
